Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-299

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant Dimeglumine (NDC 55150-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel -150 mg Per Vial (Container Label)

Package Label-principal Display Panel -150 mg Per Vial (Container Label)
This is a description of a medication called Fosaprepitant for Injection. It comes in a single-dose vial with 150 mg of the active ingredient fosaprepitant. The vial should be stored in a refrigerator between 2°C and 8°C. Once reconstituted, the solution is stable for 24 hours at room temperature of 25°C or below. The usual dosage should be referred to in the prescribing information. The medication is for intravenous use only and is distributed by AuroMedics Pharma LLC. The text also includes the NDC code and some symbols that are not informative.*
FDA Label Image

Package Label-principal Display Panel -150 mg Per Vial – Container-carton (1 Vial) (Fosaprepitant Fig2)

Package Label-principal Display Panel -150 mg Per Vial – Container-carton (1 Vial) (Fosaprepitant Fig2)
This is a drug called Fosaprepitant for injection. Each vial contains 150mg of the drug and it should be mixed with 5mL of 0.9% Sodium Chloride for Injection. It should be used intravenously only and it is not recommended to be used with any solution that contains divalent cations (0.9 Ca%, Mg) such as Lactated Ringer's Solution and Hartmann's Solution. The product should be refrigerated at 2-8°C (36-46°F) and the vial should be discarded if any portion of the drug is unused. The label mentions the name of the manufacturer (Auromedics Pharma LLC) and other additional details about the inactive ingredients, recommended dosage, and storage temperature.*
FDA Label Image

Fosaprepitant Dimeglumine Chemical Structure (Fosaprepitant Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.